Dr. Klaus Wagenbauer

Co-founder and CEO of Plectonic is a physicist and leader in the field of DNA origami. Klaus is credited with co-inventing the groundbreaking LOGIBODY and Ultra-Beacon technologies, which have the potential to revolutionize next-generation cancer Immunotherapeutics.

Since 2022, he has been serving as the CEO of Plectonic Biotech, a spin-off from the Technical University of Munich, funded by the German Agency for Disruptive Innovation.

Klaus holds a Ph.D. from the Technical University of Munich and has made significant contributions to the field of DNA nanotechnology throughout his academic career. His research has been published in prestigious journals such as Science and Nature, and he is the inventor on several patents in the field. In recognition of his outstanding achievements, Klaus has received numerous awards, including his induction into the Young Academy of the Bavarian Academy of Sciences and his selection as one of the “Top 40 under 40” in 2023.